FDA approves Roche drug for late-stage breast cancer

Comments (2)
Seer wrote:

Pardon my skepticism, but one more polysylabic poison for end stage cancer will not save lives. It will, however, hasten their death and make 1.9 billion for Roche labs.

Feb 22, 2013 11:44am EST  --  Report as abuse

An example, it shrinks but doesn’t cure. So instead of curing it, or 300 extra years of life you get 2, and 50 people get paid to sit on there but and do nothing. Its the end, especially if its 50% of the EU and US economy. The rest of the world is better off not listening to or abiding by a single corporate law they pass, the US or EU, as in the end, everyone would drive to South America or fly to China for a cure, as it would in the end be cheaper.. And so is the rest of humanity…

Feb 22, 2013 2:29pm EST  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.